Some U.S. patients reporting COVID rebounds after taking Pfi

As Paxlovid has become more widely used, some patients have reported that COVID-19 symptoms recurred after completing treatment.

Related Keywords

Germany , United States , Toronto , Ontario , Canada , American , Mikael Dolsten , William Pao , Albert Bourla , Pfizer , Us Centers For Disease , Pfizer Inc , Postmedia Network Inc , Drug Administration , Reuters , Chief Development Officer William Pao , Executive Albert Bourla , Disease Control , Postmedia Network , Street East ,